Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,229 | 29,487 | 5,496 | 4,350 | 22,212 |
| Marketable Securities | 753 | 3 | N/A | N/A | N/A |
| Receivables | 1,645 | 1,420 | 1,115 | N/A | N/A |
| Inventories | N/A | 266 | 179 | 55 | 51 |
| TOTAL | $47,237 | $32,405 | $7,950 | $7,180 | $24,955 |
| Non-Current Assets | |||||
| PPE Net | 7,539 | 2,858 | 2,998 | 1,349 | 1,348 |
| Investments And Advances | 4,671 | 0 | 0 | 0 | 0 |
| Intangibles | 33,592 | 38,848 | 46,208 | 20,487 | 18,620 |
| Other Non-Current Assets | 1,621 | 790 | 574 | 734 | 907 |
| TOTAL | $47,423 | $42,496 | $49,780 | $22,569 | $20,874 |
| Total Assets | $94,660 | $74,901 | $57,730 | $29,749 | $45,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,377 | 6,803 | 6,723 | 3,990 | 2,681 |
| TOTAL | $12,462 | $7,069 | $6,958 | $4,391 | $3,147 |
| Non-Current Liabilities | |||||
| Long Term Debt | 220 | 0 | N/A | N/A | N/A |
| Deferred Revenues | 2,952 | 208 | 235 | 401 | 466 |
| Other Non-Current Liabilities | 15,875 | 7,833 | 9,222 | 4,118 | 2,187 |
| TOTAL | $5,751 | $5,109 | $8,510 | $1,063 | $1,225 |
| Total Liabilities | $18,213 | $12,178 | $15,467 | $5,454 | $4,372 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,894 | 83,155 | 69,599 | 54,907 | 50,322 |
| Common Shares | 273,979 | 234,850 | 203,456 | 119,821 | 115,145 |
| Retained earnings | -229,893 | -182,190 | -145,779 | -101,896 | -80,470 |
| Other shareholders' equity | 50,361 | 26,563 | 27,490 | 14,275 | 12,689 |
| TOTAL | $76,447 | $62,723 | $42,262 | $24,294 | $41,458 |
| Total Liabilities And Equity | $94,660 | $74,901 | $57,730 | $29,749 | $45,830 |